Responders and non-responders to drug treatment in social phobia: Differences at baseline and prediction of response

Journal of Affective Disorders

Volumn 39, Issue 1, 1996, Pages 13-19

  Slaap, Bernhard R ^a   Van Vliet, Irene M ^b   Westenberg, Herman G M ^b   Den Boer, Johan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Drug therapy; Heart rate; Prediction of response; Social phobia

Indexed keywords

BROFAROMINE; FLUVOXAMINE; OXAZEPAM;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOBIA; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOPHARMACOTHERAPY;

EID: 0030594653     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(96)00013-4     Document Type: Article

References (26)

1. Akselrod, S., Gordon, D., Ubel, F.A., Shannon, D.C., Barger, A.C. and Cohen, R.J. (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213, 220-222.
2. Akselrod, S., Gordon, D., Madwed, J.B., Snidman, N.C., Shannon, D.C. and Cohen, R.C. (1985) Hemodynamic regulation: investigation by spectral analysis. Am. J. Physiol. 249, H867-H875.
3. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders (3rd. Edn.) DSM-III. American Psychiatric Press, Washington, DC.
4. Basoglu, M., Marks, I.M., Swinson, R.P., Noshirvani, H., Osullivan, G. and Kuch, K. (1994) Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure. J. Affect. Disord. 30, 123-132.
5. Black, D.W., Wesner, R.B., Gabel, J., Bowers, W. and Monahan, P. (1994) Predictors of short-term treatment response in 66 patients with panic disorder. J. Affect. Disord. 30, 233-241.
6. Derogatis, L.R., Lipman, R.S. and Covi, L. (1973) SCL-90: An outpatient psychiatric rating scale: preliminary report. Psychopharmacol. Bull. 9, 13-28.
7. Fyer, A.J., Mannuzza, S., Gallops, M.S., Martin, L.Y., Aaronson, C., Gorman, J.M., Liebowitz, M.R. and Klein, D.F. (1990) Familial transmission of simple phobias and fears. A preliminary report. Arch. Gen. Psychiatry 47, 252-256.
8. Gelernter, C.S., Uhde, T.W., Cimbolic, P., Arnkoff, D.B., Vittone, B.J., Tancer, M.E. and Bartko, J.J. (1991) Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch. Gen. Psychiatry 48, 938-945.
9. Hamilton, M. (1959) The assesment of anxiety states by rating. Br. J. Med. Psychol. 32, 50-55.
10. Hamilton, M. (1967) Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6, 278-296.
11. Klein, E., Cnaani, E., Harel, T., Braun, S. and Benhaim, S.A. (1995) Altered heart rate variability in panic disorder patients. Biol. Psychiatry 37, 18-24.
12. Liebowitz, M.R. (1987) Social Phobia. Mod. Probl. Pharmacopsychiatr. 22, 141-173.
13. Mavissakalian, M. and Hamann, M.S. (1987) DSM-III personality disorder in agoraphobia. II. changes with treatment. Compr. Psychiatry 28, 356-361.
14. Noyes, R., Jr., Anderson, D.J., Clancy, J., Crowe, R.R., Slymen, D.J., Ghoneim, M.M. and Hinrichs, J.V. (1984) Propanolol and diazepam in panic disorder and agoraphobia. Arch. Gen. Psychiatry 41, 287-292.
15. Reich, J., Goldenberg, I., Goisman, R., Vasile, R. and Keller, M. (1994) A prospective, follow-along study of the course of social phobia. 2. Testing for basic predictors of course. J. Nerv. Ment. Dis. 182, 297-301.
16. Reich, J. and Yates, W. (1988) Family history of psychiatric disorders in social phobia. Compr. Psychiatry 29, 72-75.
17. Reich, J.H. (1988) DSM-III personality disorders and the outcome of treated panic disorder. Am. J. Psychiatry 145, 1149-1152.
18. Rosenberg, R., Bech, P., Mellergard, M. and Ottosson, J.O. (1991) Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response. Acta Psychiatr. Scand. Suppl. 365, 46-52.
19. Scheibe, G., Nutzinger, D., Buller, R. and Walther, A.U. (1992) Pretreatment anxiety level as differential predictor in outpatients with panic disorder. Arzneimittelforschung 42, 1090-1094.
20. Slaap, B.R., van Vliet, I.M., den Boer, J.A. and Westenberg, H.G.M. (1995) MHPG and heart rate as correlates of non-response to drug therapy in panic disorder patients. (submitted for publication)
21. Stein, M.B., Asmundson, G.J.G. and Chartier, M. (1994) Autonomic responsivity in generalized social phobia. J. Affect. Disord. 31, 211-221.
22. Turner, R.M. (1987) The effects of personality disorder on the outcome of social anxiety symptom reduction. J. Personal. Disord. 1, 136-143.
23. van Vliet, I.M., den Boer, J.A. and Westenberg, H.G.M. (1992) Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur. Neuropsychopharmacol. 2, 21-29.
24. van Vliet, I.M., den Boer, J.A. and Westenberg, H.G.M. (1994) Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine. Psychopharmacology 115, 128-134.
25. Versiani, M., Mundim, F.D., Nardi, A.E. and Liebowitz, M.R. (1988) Tranylcypromine in social phobia. J. Clin. Psychopharmacol. 8, 279-283.
26. Woodman, C.L., Noyes, R., Ballenger, J.C., Lydiard, R.B., Sievers, G. and Mihalko, D. (1994) Predictors of response to alprazolam and placebo in patients with panic disorder. J. Affect. Disord. 30, 5-13.